Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Peene

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
RMD Open|August 8, 2024
Effectiveness of methotrexate and bridging glucocorticoids with or without early introduction of a 6-month course of etanercept in early RA: results of the 2-year, pragmatic, randomised CareRA2020 trialDelphine Bertrand, Johan Joly, Barbara Neerinckx, et al.
The Lancet. Rheumatology|January 24, 2026
Patient partnership model in rare and complex rheumatological conditions: research and beyond in European Reference Network ReCONNETJeanette Andersen, Rosaria Talaric, Diana Marinello, et al.
The Lancet. Respiratory Medicine|November 10, 2021
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trialJozefien Declercq, Karel F A Van Damme, Elisabeth De Leeuw, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
RMD Open|August 8, 2024
Effectiveness of methotrexate and bridging glucocorticoids with or without early introduction of a 6-month course of etanercept in early RA: results of the 2-year, pragmatic, randomised CareRA2020 trialDelphine Bertrand, Johan Joly, Barbara Neerinckx, et al.
The Lancet. Rheumatology|January 24, 2026
Patient partnership model in rare and complex rheumatological conditions: research and beyond in European Reference Network ReCONNETJeanette Andersen, Rosaria Talaric, Diana Marinello, et al.
The Lancet. Respiratory Medicine|November 10, 2021
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trialJozefien Declercq, Karel F A Van Damme, Elisabeth De Leeuw, et al.
Pageof 3